A detailed history of Saxony Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Saxony Capital Management, LLC holds 1,704 shares of ABBV stock, worth $341,669. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,704
Previous 2,396 28.88%
Holding current value
$341,669
Previous $411 Million 18.12%
% of portfolio
0.31%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $113,377 - $137,936
-692 Reduced 28.88%
1,704 $336 Million
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $154 - $180
-1 Reduced 0.04%
2,396 $411 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $8,310 - $9,469
-52 Reduced 2.12%
2,397 $437 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $336,982 - $379,521
2,449 New
2,449 $380 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Saxony Capital Management, LLC Portfolio

Follow Saxony Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saxony Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saxony Capital Management, LLC with notifications on news.